Natural Gums and Mucilage as Gelling agents in Topical Gel Formulation

 

Krishna Kumari J, Bandaru Hemanth Kumar, Prasanthi D*

Department of Pharmaceutics, G. Pulla Reddy College of Pharmacy,

Mehdipatnam, Hyderabad, Telangana – 500028.

*Corresponding Author E-mail: prasanthidhanu@gmail.com

 

ABSTRACT:

The study was conducted to study the gelling efficiency of natural gums (tamarind seed gum) and mucilage (moringa mucilage) using ibuprofen as model drug. Topical drug delivery (TDS) eliminates first pass metabolism and improves bioavailability. Hydrogels are dispersions of network of polymer chains in water as colloidal gels. Ibuprofen an anti-inflammatory, was chosen as a model drug in the preparation of hydrogel for site targeted action and to avoid side effects. Physical properties like swelling index, solubility, loss on drying, flow properties were evaluated. Chemical characterization of isolated gum and mucilage revealed presence of polysaccharides. Ibuprofen topical gels with natural gum (tamarind seed gum (1-7%), moringa mucilage (2-8%) were compared with official xanthan gum (1-4%), guar gum (1-3%) as natural gelling agents and HPMC K4M (1-6%), HPMC K100M (1-6%) and sodium alginate (2-6%) as semi synthetic gelling agents.  Drug and excipients are compatible with each other by FTIR studies. The prepared gel formulations were evaluated for clarity, homogeneity, spreadability, drug content, in-vitro diffusion, ex-vivo permeation, skin irritation and stability studies. All formulations have shown better physicochemical properties. Based on the maximum percentage of drug release, formulations containing natural polymers tamarind seed gum (5%), moringa mucilage (8%), xanthan gum (4%), guar gum (3%) were optimized. And semi synthetic polymers HPMC K4M (4%), HPMC K100M (3%), sodium alginate (6%) were optimized. NF10 formulation with guar gum (3%) is optimized based on the percentage of drug release (27.0±0.14%) for 8 hrs, flux of (427.2±0.09µg/cm2/hr), cumulative amount of drug permeated Q8 (329±1.53µg/cm˛) and permeability coefficient of (17.08±1.04 ×10-3cm/hr) when compared with tamarind gum (5%), NF1 (23.8±0.13%), (290±1.04µg/cm˛), (376.6±0.04µg/cm2/hr), (15.04±0.03×10-3cm/hr) and moringa mucilage (8%), NF3 (14.3±0.19%), (175±0.90µg/cm˛), (227.1±0.03µg/cm2/hr), (9.08±0.02×10-3cm/hr). The drug release pattern was found to follow first order kinetics and korsemeyer peppas release mechanism with fickian diffusion release. Formulations were found to be non-irritant and stable. Tamarind gum and moringa mucilage were efficient as gelling agent in preparation of ibuprofen topical gel but showed retarding effect when compared with official guar gum.

 

KEYWORDS: Topical drug delivery system, Ibuprofen, Anti-inflammatory agent, moringa mucilage and natural gums.

 

 


INTRODUCTION:

Polymers derived from plant origin have evoked tremendous interest due to their diverse applications in drug delivery as a disintegrant, gelling agent, emulsifying agent, suspending agents and as binders1. These natural excipients are biocompatible, cheap, less toxic, non-irritant, soothing action and simply available than the synthetic ones2,3.

 

Gums are formed by gummosis, a process of disintegration of internal plant tissues. This results in cavities, which exudates transformed carbohydrates called gums. Mucilage’s are metabolic products (physiological products), formed within the cell (intracellular formation)4. Gums dissolve in water and mucilages form slimy masses. Both gums and mucilage’s are plant hydrocolloids yielding mixture of sugars and uronic acids on hydrolysis5. Tamarind gum is a polysaccharide composed of glucosyl: xylosyl: galactosyl within the ratio of 3:2:1. It's used as gelling agent, thickening, suspending, stabilizers, emulsifying agent4. Moringa oleifera gum is obtained from exudes of stem of Moringa oleifera (family: Moringaceae). The gum may be a polyuronide constituting Arabinose, galactose and glucuronic acid5 10: 7: 2. It's used as a tablet binder, emulsifiers, gelling agents, suspending agents, stabilizers, and thickeners. Guar gum called as guaran, is galactomannan polysaccharide extracted from guar beans that has thickening and stabilizing properties useful in food, feed, and industrial applications6. The guar seeds are mechanically dehusked, hydrated, milled and screened7. Xanthan gum is produced by fermentation of simple sugars, and derives its name from the species of bacteria used, campestris. This is often an equivalent bacterium liable for causing plant disease to make on broccoli, cauliflower, and other leafy vegetables. Ibuprofen, a non-selective COX inhibitor, decreases the synthesis of prostaglandins involved in mediating inflammation and is assumed to cause a number of the side effects including GI ulceration8,9. There's great interest to develop non-oral dosage form of ibuprofen to attenuate its gastric side effects, while at an equivalent time delivering consistent drug levels at the application site for prolonged periods10. Hence, it's been envisaged to formulate ibuprofen topical gel to avoid the systemic side effects, using natural gums, mucilage like tamarind seed gum, moringa mucilage, xanthan gum, guar gum as gelling agent. And comparison with synthetic gelling agents.

 

MATERIALS AND METHODS:

Materials:

Ibuprofen was gifted by Medico Remedies Pvt. Ltd., tamarind seed powder was purchased from Local Market, moringa gum was purchased from Jagadish enterprises, xanthan gum and guar gum was purchased from Yarrow chem products, Carbopol was gifted from RA Chem pharma Ltd., glycerin, propylene glycol, isopropyl alcohol, benzoic acid, tri-ethanolamine were procured from S.D. Fine Chemicals Ltd.

 

Drug-excipient compatibility study:

Interactions by FTIR:

The spectrum analysis of pure drug and physical mixture of drug with different excipients which are used for preparation of gel was studied by FTIR by KBr pellet method using shimadzu (Koyto, Japan) facility (model-8400S). They were observed for the presence of characteristic peaks for the respective function11. The resultant spectrum was compared for any spectra changes.

 

Isolation of natural polymers:

Isolation of tamarind seed gum:

To 20g of tamarind seed powder, 200ml of cold water was added and slurry was prepared. This was added to 800ml boiling water and boiled for 20min. It was then kept aside overnight and then centrifuged for 20 min at 5000rpm. To the supernatant absolute ethanol was added and precipitated mass was pressed between felt. The precipitate was washed with absolute ethanol, diethyl ether and then dried at 50-60°C under vacuum. The dried material was ground and sieved through 100 mesh (Figure 1) and stored in a desiccator until used for further studies12.

 

 

 

 


Figure 1: In the extraction of tamarind seed gum

a) Precipitated mass and b) tamarind seed gum powder.                     

 

Isolation of Moringa gum:

Dried gum (10 g) was stirred in water (250 ml) for 6-8hr at temperature 30°C. The supernatant was obtained by centrifugation. The residue was washed with water and the washings were added to separated supernatant. The procedure was repeated four more times. Finally, the supernatant was treated with twice the quantity of acetone by continuous stirring. The precipitated material was washed with distilled water and dried at 50-60° under vacuum and sieved to form mucilage powder 5 (Figure 2).

 

b

 

b

 
 


Figure 2: In the extraction of moringa gum a) Precipitated mass and b) moringa mucilage powder.   

 

Evaluation of isolated tamarind seed gum and moringa mucilage:

Organoleptic evaluation of isolated gum and mucilage powder:

The isolated gum powder and mucilage powder was characterized for organoleptic properties like colour, odour, taste, fracture, and texture.

Solubility of isolated gum and mucilage:

One part of dry gum and mucilage powder separately was shaken with different solvents and solubility was determined13.

 

pH of gum and mucilage powder:

The gum and mucilage powder were weighed and dissolved in water separately to prepare 1% w/v solution. The pH of solution was studied using digital pH meter

 

Swelling index:

The swelling index was determined by accurately weighing 500 mg of sample and 25ml of water was added and mixture was shaken thoroughly every 10 min for 1hr. It was then allowed to stand at room temperature for 3 hrs. Then the quantity occupied by gum, was measured. The same procedure was repeated thrice and the mean value was calculated14.

z

Loss on drying:

Specific amount of sample was taken and its weight was measured and it was placed in a hot air oven maintained at temperature 70°C for 30 minutes. After 30 minutes, the sample was weighed and the process was repeated till constant weight was achieved.  Final Loss on drying is calculated using formula

 

                      Mass of waste in sample

LOD (%) = ––––––––––––––––––––––––– × 100

                     Total weight of wet sample

 

Micromeritic properties of isolated gum and mucilage powder15:

Bulk density, tapped density and angle of repose were determined by taking the weight of sample, bulk volume and tapped volume. Angle of repose was determined by using the standard funnel method.

Preliminary confirmation test for gum and mucilage powder15:

Molisch’s test:

100 mg of dried mucilage powder was taken in a test tube. To this dried mucilage powder Molisch’s reagent was added and conc.H2SO4 was added along the sides of the test tube.

 

Ruthenium test:

A small quantity of dried mucilage powder was taken on a slide with ruthenium red solution and observed under microscope.

 

Iodine test:

100 mg of dried mucilage powder was taken in a test tube and 1 ml of 0.2N Iodine solution was added to it.

 

Preparation of gels16:

Different concentrations of isolated tamarind seed gum powder (1% to 7%), moringa gum mucilage powder (2% to 8%), xanthan gum (1% to 4%), guar gum (1% to 3%), HPMCK4M (1% to 6%), HPMCK100M (1% to 6%) and sodium alginate (2% to 6%) were initially tried as gelling agents. Based on optimum gel consistency, concentration of each gelling agent was selected and then formulated as gels with drug 15%w/w (according to IP monograph). Glycerin or propylene glycol or PEG 400 were added as plasticizer and benzoic acid as preservative. The dispersion was allowed to stand at room temperature for 1 hour to obtain viscous mixture. The required quantity of tri-ethanolamine was then added to gel by mixing gently for adjustment of skin pH. The formulation table of gels with natural polymers is given in table 1 and with semi synthetic polymers is given in table 2.


 

Table 1:  Formulation of ibuprofen topical gels with different concentrations of natural polymers

Ingredients

NF1

NF2

NF3

NF4

NF5

NF6

NF7

NF8

NF9

NF10

Drug (g)

1.5

1.5

1.5

1.5

1.5

1.5

1.5

1.5

1.5

1.5

Tamarind seed gum (%)

5

7

-

-

-

-

-

-

-

-

Moringa gum mucilage (%)

-

-

8

-

-

-

-

-

-

-

Xanthan gum (%)

-

-

-

1

2

3

4

-

-

-

Guar gum (%)

-

-

-

-

-

-

-

1

2

3

Glycerin (%)

10

10

10

-

-

-

-

-

-

-

Propylene glycol (%)

-

-

-

10

10

10

10

10

10

10

Benzoic acid (%)

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

0.1

Isopropyl alcohol (ml)

3

3

3

3

3

3

3

3

3

3

Triethanolamine (%)

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Distilled water

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Total weight of gel (g)

10

10

10

10

10

10

10

10

10

10

 

Table 2: Formulation of ibuprofen topical gels with different concentrations of semi synthetic polymers

Ingredients

SF1

SF2

SF3

SF4

SF5

SF6

SF7

SF8

Drug (g)

1.5

1.5

1.5

1.5

1.5

1.5

1.5

1.5

HPMC K4M (%)

4

5

6

-

-

-

-

-

HPMC K100M (%)

-

-

-

3

4

5

6

-

Sodium alginate (%)

-

-

-

-

-

-

-

6

 PEG 400 (%)

10

10

10

10

10

10

10

10

Propanol (%)

30

30

30

30

30

30

30

30

Distilled water

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Q.S

Total weight of gel (g)

10

10

10

10

10

10

10

10


The topical gels of ibuprofen were evaluated for the following parameters.

 

Clarity17:

Clarity of prepared ibuprofen hydrophilic gel was determined by visual inspection and it was graded as follows: turbid +, clear ++, very clear +++.

 

Homogeneity18:

Gels are tested for homogeneity by visual inspection. They are tested for their appearance and presence of any aggregates.

 

pH Measurement19:

The pH of formulated gels is determined by using digital pH meter. 1g of gel is dissolved in 100ml distilled water and stored for two hours. The measurement of pH of each formulation is done in triplicate and average values are calculated.

 

Viscosity Measurement20:

Viscosity of prepared gels was determined by Brookfield programmable viscometer LVDV-II+PRO. The spindle number 64 was rotated at 20rpm. Samples of the gels were allowed to settle over 30 minutes at the temperature (25±1°C) before measuring.

 

Spreadability15:

For the determination of spreadability, 1g of sample was applied between the two 20x20cm glass slides and was compressed by placing 10g weight for 1min. The distance moved by gel due to pressure was measured as length. Using the given formula spreadability (S) was calculated.

 

S = M.L / T

Where,

S = Spreadability, M = Weight tide to the upper slide, L = distance moved by gel, T = Time of study.

 

Extrudability15:

The extrudability test was performed by Pfizer hardness tester. Gel was filled in aluminum tube and plunger was adjusted to hold the tube properly, pressure was applied for 30 sec. The quantity of gel extruded was weighed. Test was carried in triplicate.

 

Drug content:

Gel sample equivalent to 5mg of drug was taken into 100ml volumetric flask of phosphate buffer saline (pH 7.4). The sample was dissolved and filtered. With appropriate dilutions the sample was analysed at 224nm by UV Spectrophotometric method.

 

In-Vitro Drug Release Studies by Diffusion studies16:

The formulated gels were studied using open end tube method. Dialysis membrane was fixed to one end of the cylinder and 500mg of the prepared gel was placed. This was immersed in a beaker containing 250ml of buffer, which was agitated by magnetic stirrer and temperature maintained at 37˚±1˚C. Samples were withdrawn at periodic intervals and analysed spectrophotometrically at 224nm.

 

Ex-vivo permeation studies16:

Ex-vivo permeation studies were performed using rat abdominal skin. The study was performed with approval from Institutional animal ethical committee GPRCP/IAEC/09/19/11/PCL/AE/5/RATS-M/F-30. Locally fabricated Franz diffusion cells with 25ml receptor volume were used. The excised rat skin was mounted onto diffusion cell. 500mg of gel was applied to the donor compartment and the hydrodynamics in the receptor compartment were maintained by stirring on magnetic stirrer at 600rpm. 1ml sample was withdrawn at predetermined time intervals for 24 hours and drug content was analyzed by UV-VIS double beam spectrophotometer at 224nm.

 

Ex-vivo permeation rate parameters such as % drug release, cumulative amount permeated in 24hrs (Q24), steady state transdermal flux (SSTF), permeability coefficient and lag time for percutaneous absorption of ibuprofen were calculated. Various models were tested for explaining the kinetics of drug release. Data was fitted into zero-order, first order, Higuchi and Korsemeyer-peppas release model.

 

Skin irritation studies16:

Skin irritation studies were performed on rabbits after the approval by the Institutional animal ethical committee. A primary skin irritation test was performed on three healthy rabbits weighing between 1.5-2kg. Gels was applied (0.5g/animal) twice a day for 7 days. The site was observed for any sensitivity and reaction, if any was observed it was graded as 0,1,2,3 for no reaction, slight patchy erythema, slight but confluent or moderate but patchy erythema and serve erythema with or without edema, respectively.

 

Stability test :

Optimised formulations of natural and semi-synthetic polymers were subjected to stability at room temperature for one month. The physicochemical properties and drug content were evaluated every week.

 

RESULTS AND DISCUSSION:

Compatibility studies by Fourier Transform Infrared spectroscopy were carried out to study the possible interaction between Ibuprofen and other excipients.

 

The various FTIR graphs both of pure drug and various excipients in combination are given in Figure no 3. The wave numbers of the principal peaks (2953.45 cm-1; 2360.44 cm-1; 1720 cm-1; and 1227.47 cm-1) of Ibuprofen indicating the presence of aliphatic methylene group, hydroxyl group, ketone group and alkyl group respectively, appeared as characteristic peaks in the IR graphs of the pure drug and physical mixture of drug with excipient.


A

 

B

 

C

 

D

 

Figure 3: FTIR graph of A) pure drug (Ibuprofen)                               B) Ibuprofen +Tamarind seed gum powder

                                           C)  Ibuprofen + Moringa gum mucilage       D) Ibuprofen + Guar gum

 

Table 3: Physicochemical properties and flow properties of isolated gum and mucilage

Parameters

Organoleptic

Solubility

pH

Swelling index

Loss on drying (%)

Bulk density g/cc

Tapped density g/cc

Angle of repose (θ)

Tamarind seed gum

Light brownish in color with rough texture and rough fracture, odorless.

Soluble in hot water, insoluble in organic solvent such as benzene, ether, chloroform

6.7

11.2±

0.02

0.0052±

0.05

0.442±

0.04

0.589±

0.05

26.5±

0.02

Moringa mucilage

White colour but changes to reddish brown or brownish exposure.

Sparingly soluble in water forming viscous solution, insoluble in ethanol, methanol, acetone, ether.

5.77

19.7±

0.94

0.0068±

0.06

0.716±

0.12

0.895±

0.05

30.8±

0.01

Note: Values are expressed as Mean ±SD, n=3

 


This indicates no interaction between drug and excipient and that the pure drug was not altered functionally. Thus, the excipients were found to be compatible. So, polymers can be employed for the topical drug delivery of ibuprofen.

 

The isolated gum and mucilage were evaluated for organoleptic, solubility, pH, swelling index, loss on drying and flow properties. The physicochemical properties of isolated gum and mucilage were within limits (Table 3). Isolated gum and mucilage showed good flow properties. Gum and mucilage showed swelling properties indicating they can be used as gelling agent. The isolated gum and mucilage powders were evaluated for chemical characterization such as Molisch test, Ruthenium test, Iodine test. In Molisch test violet green colour was observed at the junction of two layers, in ruthenium test pink colour was developed and in iodine test no colour was developed in the solution indicating the presence of carbohydrates, mucilage and polysaccharides respectively.

 

All the prepared ibuprofen topical gels with natural polymers and synthetic polymers were evaluated for their physicochemical properties such as clarity, pH, viscosity, spreadability, extrudability, homogeneity, and drug content. The gels were found to be clear, homogenous, with optimum pH for skin application, optimum viscosity required for gel formulation, good spreadability, better extrudability from packaging and drug content.

 

Invitro diffusion study was determined by dialysis membrane. From the results, it was seen that NF1 formulation containing tamarind seed gum 5% showed 23.8±0.13% release for 8 hrs, NF3 formulation containing moringa mucilage 8% showed 14.3±0.19% release for 8 hrs, NF7 formulation containing xanthan gum 4% showed 14.4±0.11% release for 8 hrs, NF10 formulation containing guar gum 3% showed 27.0±0.13% release for 8 hrs. So, these are optimized, and further compared with the optimized ibuprofen topical gels of semi synthetic polymers. In in-vitro release studies it was seen that SF1 formulation containing HPMC K4M 4% showed 17.47±0.21% release for 8 hrs, SF4 formulation containing HPMC K100M 3% showed 19.17±0.09% release for 8 hrs, SF8 formulation containing sodium alginate 6% showed 10.2±0.13% release for 8 hrs.

 

These optimised formulations were further evaluated for ex-vivo permeation studies using rat abdominal skin. The percent drug release graph is given in figure 4 and permeability parameters are given in table 4. From table 4, the formulation NF10 has shown the maximum cumulative amount permeated of drug Q8 329±1.53 µg/cm˛, flux 427±0.09µg/cm2/hr and permeability coefficient 17.08±1.04×10-3cm/hr.

 

Figure 4: Ex-vivo permeation of ibuprofen topical gel of natural polymers and semi synthetic polymer

 

Table 4: Permeability parameters of drug /through the dialysis membrane of optimized formulations

Formulation

Q8 (µg/cm2)

Flux

(µg/cm2/hr)

Permeability coefficient (cm/hr×103)

NF1

290±1.04

376.6±0.04

15.04±0.03

NF3

175±0.90

227.1±0.03

9.08±0.02

NF7

175±2.00

227.2±0.02

9.08±0.04

NF10

329±1.53

427.2±0.09

17.08±1.04

SF1

195.1±0.90

253.2±0.06

10.1±0.02

SF4

226±1.04

293.5±0.04

11.7±0.04

SF8

140±2.38

181.8±0.03

7.24±0.03

Note: Values are expressed as Mean ±SD, n=3

 

From the drug release kinetics, the formulations were found to follow first order kinetics and Korsemayer peppas release mechanism with Fickian diffusion release.

 

The formulations were evaluated for skin irritation studies using rabbit model. Formulations did not produce any signs of erythema or edema. Formulations were also found to be stable at room temperature for a period of one month.

 

CONCLUSION:

Ibuprofen topical gels were prepared for site targeted action using natural polymers such as (tamarind seed gum, moringa mucilage, xanthan gum, guar gum) and semi synthetic polymers such as (HPMC K100, HPMCK4, sodium alginate). Isolated natural gums such as (tamarind seed gum, moringa mucilage) was extracted by using absolute ethanol, acetone as non-solvent. Physicochemical characteristics such as solubility, swelling index, loss on drying, pH, flow properties showed excellent results. Molisch’s test, Ruthenium test, Iodine test were studied and revealed presence of polysaccharides. Gels possessed good physico chemical properties, drug excipient compatibility, were non-irritant and stable. Gels prepared from natural polymers showed better permeation then semi-synthetic polymers. Hence it is concluded that isolated natural gum and mucilage (tamarind seed gum and moringa mucilage) can be used as gelling agent in formulation of topical gels.

 

REFERENCES:

1.      Kulkarni G.T, K. Gowthamarajan R. R. Dhobe F. Yohanan and B. Suresh. Development of controlled release spheroids using natural polysaccharide as release modifier. Drug Delivery. 2005; 12(4): 201–206. doi: 10.1080/10717540590952537

2.      Kokate D.C.K, A. P. Purohit and S. B. Gokhale. Pharmacognosy, Nirali Prakashan, 29th edition, 2008.

3.      Jain NK, Misra AN. Controlled and Novel Drug Delivery, CBS Publishers and Distributors, New Delhi,1st edition, 2005. 

4.      Loveleen Preet Kaur, Rajeev Garg, GD Gupta. Topical gels: A review. Research J. Pharm. and Tech. 2010; 3(1): 17-24.

5.      Panda D, S. Swain, R. Gupta and S. K. Kanungo. Preparation and evaluation of gels from gum of Moringa oleifera. Indian Journal of Pharmaceutical Sciences. 2006; 68(6): 777–780.                       DOI: 10.4103/0250-474X.31014

6.      Nikunj Patel, Ashok Kumar P, Basavaraj, Tom Damien, Someshwara Rao B, Suresh V Kulkarni. Use of Hydrophilic Natural Guar Gum in Formulation of Controlled-Release Matrix Tablets of Metformin Hydrochloride and Its Comparison with Marketed Product. Research J. Pharma. Dosage Forms and Tech. 2010; 2(2):193-197.

7.      Amit Kumar Panigrahi, Mathrusri M. Annapurna, K. Himashankar. Guar Gum Microspheres of 5-Fluorouracil for Colon Targeting. Research J. Pharm. and Tech. 2012;5(2): 267-272.

8.      Bazigha K Abdul Rasool, Oman F Abu-Gharbieh, Saharan A Fahmy, Heyam S Saad and Saeed A Khan.  Development and Evaluation of Ibuprofen Transdermal Gel Formulations. Tropical Journal of Pharmaceutical, 2010; 9 (4), 355-363.

9.      Amit K. Jain, Rajput Rammulrajsinh, Pradeep Agrawal, Kinal patel. Design and Evaluation of Sustained Release Matrix Tablets of Ibuprofen. Research J. Pharma. Dosage Forms and Tech. 2011; 3(4):142-147.

10.    Ghassan Z Abdullah, Muthanna F Abdulkarim. In vitro permeation and in vivo anti- inflammatory and analgesic properties of nanaoscaled emulsions containing ibuprofen for topical delivery. International Journal of Nanomedicine. 2011; 6: 387-396. doi: 10.2147/IJN.S14667

11.    Mahdi Abd Zair, D. Prasanthi, Amoolya Chennuri, Zainab Rahi Hanthal, P K Lakshmi. Effect of Transcutol and Stearylamine on Ibuprofen Hydrophilic Gel for Transdermal Delivery. International Journal of Drug Delivery Technology. 2018; 8(1): 6-14. doi: 10.25258/ijddt.v8i01.11901

12.    Kailas K. Mali, Shashikant C. Dhawale, Remeth J. Dias. Extraction, Characterization and Functionalization of Tamarind Gum. Research J. Pharm. and Tech. 2019; 12(4):1745-1752. doi:10.5958/0974-360X.2019.00292.0

13.    M. U. Mishra and J. N. Khandare. Evaluation of tamarind seed polysaccharide as a biodegradable carrier for colon specific drug delivery. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(1): 139–142.

14.    Shruti Panwar, Sangeeta Loonker. Synthesis of Novel Film of Poly Vinyl Alcohol Modified Guar Gum with Tamarind seed Kernel Powder and its Characterization. Asian J. Research Chem. 2017; 10(5): 616-620. doi: 10.5958/0974-4150.2017.00103.

15.    Niyaz BB.  Formulation and evaluation of Gel containing Fluconazole-Antifungal agent. International Journal of Drug Development and Research. 2011; 3(4): 109-128

16.    Prasanthi D, Kuruva Jyothirmai, P. K. Lakshmi. Optimisation Alfuzosin Hydrochloride Organogels for Transdermal Delivery. British Journal of Pharmaceutical Research. 2016;11(2): 1-16.

17.    Mazher Ahmed and Musharraf Ali. Semisolid Dosage Form: Topical Gel Formulation A Review. World J P’ceutical Rese. 2016; 5(12): 1256-1268

18.    Hemendrasinh J Rathod and Dhruti P Mehta. A Review on Pharmaceutical Gel. International Journal of Pharmaceutical Sciences. 2015; 1(1): 33-47.

19.    Kaur LP, Guleri TK. Topical Gel: A Recent Approach for Novel Drug delivery. Asian Journal of Biomedical and Pharmaceutical Sciences. 2013; 3(17): 1-5.

20.    RPS Rathore, RK Nema. Formulation and Estimation of Rheological Parameters of Topical Gels of Ketoprofen. Research J. Pharma. Dosage Forms and Tech. 2009; 1(3):226-228.

 

 

 

Received on 19.10.2021            Modified on 29.11.2021

Accepted on 26.12.2021           © RJPT All right reserved

Research J. Pharm. and Tech 2022; 15(10):4681-4686.

DOI: 10.52711/0974-360X.2022.00785